Webster Bank N. A. Has $118,000 Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Webster Bank N. A. lessened its holdings in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 44.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,825 shares of the company’s stock after selling 1,470 shares during the quarter. Webster Bank N. A.’s holdings in Invesco Biotechnology & Genome ETF were worth $118,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Kestra Advisory Services LLC increased its stake in Invesco Biotechnology & Genome ETF by 4.2% during the 3rd quarter. Kestra Advisory Services LLC now owns 6,362 shares of the company’s stock worth $363,000 after purchasing an additional 254 shares in the last quarter. Creative Financial Designs Inc. ADV increased its position in shares of Invesco Biotechnology & Genome ETF by 6.6% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 3,347 shares of the company’s stock worth $220,000 after acquiring an additional 206 shares in the last quarter. Raymond James & Associates lifted its position in Invesco Biotechnology & Genome ETF by 121.6% in the 4th quarter. Raymond James & Associates now owns 13,247 shares of the company’s stock valued at $872,000 after acquiring an additional 7,268 shares in the last quarter. Global Retirement Partners LLC acquired a new position in Invesco Biotechnology & Genome ETF in the 4th quarter worth $39,000. Finally, Stratos Wealth Partners LTD. bought a new position in Invesco Biotechnology & Genome ETF during the 4th quarter worth about $208,000.

Invesco Biotechnology & Genome ETF Price Performance

Shares of Invesco Biotechnology & Genome ETF stock opened at $64.81 on Friday. The firm has a market cap of $261.85 million, a price-to-earnings ratio of 17.12 and a beta of 0.88. The stock’s 50-day moving average is $63.71 and its 200-day moving average is $64.30. Invesco Biotechnology & Genome ETF has a one year low of $52.47 and a one year high of $67.76.

About Invesco Biotechnology & Genome ETF

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.